P217 POSTERS emissions and no difference regarding the gender (P = .2). A total of 79.9% showed abnormalities in both transient and distortion product in at least 1 ear, most were men (P < .05). In sum, 94.0% reported the use of headphones, and 82.8% reported attending some type of place with amplified music.
Method: Ouabain applied in organotypic cultures. Phalloidin and neurofilament antibody used to label hair cells and nerve tissue. In vivo, 1 mM or 10 mM ouabain applied to round window. ABR and DPOAE were recorded 7 days posttreatment. Cochlea sections were used to count SGN and nerve fibers. TUNEL staining were used to assess apoptosis.
Results: In vitro, low concentrations of ouabain only damaged spiral ganglion neurons; however, high doses destroyed both spiral ganglion neurons and cochlear hair cells. Application of 1 mM ouabain to the rat round window membrane only altered ABR thresholds and DPOAE amplitudes at higher frequencies. In contrast, 10 mM ouabain significantly increased ABR thresholds and decreased DPOAE amplitudes at almost all frequencies. Consistent with physiological results, both spiral ganglion neurons and hair cells were missing or damaged in the basal turn of the cochlea and both hair cells and neurons showed signs of apoptotic cell death.
Conclusion:
In vitro and vivo, ouabain damage was dose and time-dependent; SGN were more vulnerable than HCs. ABR thresholds increased at high frequencies with 1mM ouabain and increased at all frequencies with 10 mM ouabain.DPOAE amplitude minimally affected with 1 mM ouabain and got large reduction at all frequencies with 10 mM oubain.
Otology/Neurotology Pediatric Cholesteatoma: Congenital versus acquired
Byoung Soo Shim (presenter); Myung Joo Shim; Hyun Woo Lim; Tae Hyun Yoon Objective: 1) To compare the characteristics of congenital and acquired pediatric cholesteatoma. 2) To investigate the risk factors influencing recidivism after initial surgery to propose a guided therapeutic approach.
Method: Retrospective analysis was made on pediatric cholesteatoma cases under the age of 18 years. A total of 163 patients (92 of congenital and 71 of acquired cholesteatoma) were operated by the same surgeon from 1993 to 2011. We analyzed the symptoms, physical findings, computed tomography, operative findings, hearing, and recurrence.
Results:
The ages at diagnosis and operation in congenital cholesteatoma were significantly younger than acquired. The chief complaint of congenital was mainly the incidental mass (74%), whereas the otorrhea (66%) in acquired. Mass shadow behind the intact tympanic membrane was observed in 95% of congenital cholesteatoma. The main tympanic membrane abnormalities of acquired cholesteatoma were attic retraction and pars tensa perforation (56% and 56%). Invasion of epitympanum and ossicular erosion were more frequently found in the acquired cholesteatoma (P < .05). There was no difference in recurrence rate between congenital and acquired cholesteatoma. Statistically significant factors at high risk of recurrence were pars tensa perforation, diploic pneumatization, incus erosion. On the other hand, lowering risk factors were sclerotic mastoid on CT and no mastoidectomy.
Conclusion:
The congenital and acquired cholesteatoma showed very different clinical features. Careful eradication and continued follow-up is recommended in the children with high risk of recurrence.
